9-132897582-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000368.5(TSC1):​c.2654G>A​(p.Arg885Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,545,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R885W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000058 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

TSC1
NM_000368.5 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.99

Publications

2 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10506979).
BP6
Variant 9-132897582-C-T is Benign according to our data. Variant chr9-132897582-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 195563.
BS2
High AC in GnomAd4 at 8 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC1
NM_000368.5
MANE Select
c.2654G>Ap.Arg885Gln
missense
Exon 21 of 23NP_000359.1
TSC1
NM_001406592.1
c.2654G>Ap.Arg885Gln
missense
Exon 21 of 23NP_001393521.1
TSC1
NM_001406593.1
c.2654G>Ap.Arg885Gln
missense
Exon 21 of 23NP_001393522.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC1
ENST00000298552.9
TSL:1 MANE Select
c.2654G>Ap.Arg885Gln
missense
Exon 21 of 23ENSP00000298552.3
TSC1
ENST00000490179.4
TSL:3
c.2654G>Ap.Arg885Gln
missense
Exon 22 of 24ENSP00000495533.2
TSC1
ENST00000643875.1
c.2654G>Ap.Arg885Gln
missense
Exon 21 of 23ENSP00000495158.1

Frequencies

GnomAD3 genomes
AF:
0.0000580
AC:
8
AN:
137892
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000132
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000792
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000305
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000173
AC:
4
AN:
230744
AF XY:
0.0000160
show subpopulations
Gnomad AFR exome
AF:
0.0000637
Gnomad AMR exome
AF:
0.0000325
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000189
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000121
AC:
17
AN:
1407378
Hom.:
0
Cov.:
36
AF XY:
0.00000858
AC XY:
6
AN XY:
699050
show subpopulations
African (AFR)
AF:
0.0000948
AC:
3
AN:
31654
American (AMR)
AF:
0.00
AC:
0
AN:
39896
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23798
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36660
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80898
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49970
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5494
European-Non Finnish (NFE)
AF:
0.0000120
AC:
13
AN:
1081906
Other (OTH)
AF:
0.0000175
AC:
1
AN:
57102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000580
AC:
8
AN:
137958
Hom.:
0
Cov.:
31
AF XY:
0.0000764
AC XY:
5
AN XY:
65464
show subpopulations
African (AFR)
AF:
0.000132
AC:
5
AN:
37856
American (AMR)
AF:
0.0000791
AC:
1
AN:
12640
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3392
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4490
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4134
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6782
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
0.0000305
AC:
2
AN:
65654
Other (OTH)
AF:
0.00
AC:
0
AN:
1870
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000372
Hom.:
0
ExAC
AF:
0.0000412
AC:
5
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000547
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tuberous sclerosis 1 Uncertain:1Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tuberous sclerosis syndrome Uncertain:1
Apr 25, 2024
All of Us Research Program, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces arginine with glutamine at codon 885 of the TSC1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with TSC1-related disorders in the literature. This variant has been identified in 6/259650 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

not provided Uncertain:1
Dec 17, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary cancer-predisposing syndrome Benign:1
Dec 23, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.42
T
MutationAssessor
Benign
1.5
L
PhyloP100
2.0
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.30
N
REVEL
Uncertain
0.33
Sift
Benign
0.57
T
Sift4G
Benign
0.56
T
Polyphen
0.99
D
Vest4
0.58
MVP
0.83
MPC
1.5
ClinPred
0.24
T
GERP RS
5.6
Varity_R
0.44
gMVP
0.11
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200514807; hg19: chr9-135772969; API